Medical devices, healthcare technology and the business of care
510(k) clearance · K261338

RENASYS DYNAFLOW Kit (66807741)

Smith & Nephew Medical, Ltd. · Decision date Sep 11, 2026

MEDTECHLEDGER EXPLANATIONK261338

What did the FDA decide?

FDA's 510(k) record K261338 covers the RENASYS DYNAFLOW Kit (66807741), filed by Smith & Nephew Medical, Ltd. of Hull, GB, and classified as a Negative Pressure Wound Therapy Powered Suction Pump under 21 CFR 878.4780, product code OMP, in the General & Plastic Surgery specialty. The application was received 04/23/2026 and decided 09/11/2026 as Substantially Equivalent (SESE), a clearance to market rather than a PMA approval.

The record describes a Traditional 510(k) that was not reviewed by a third party, was not a combination product, and had no authorized Predetermined Change Control Plan. The specific components, materials or design changes distinguishing this kit from its predicate device are not stated in the available record, and the summary document itself was not retrieved. No clinical, efficacy or labeling conclusions are drawn here.

Regulatory pathway
510(k) premarket notification
Clinical specialty
General, Plastic Surgery
Decision date
Sep 11, 2026
FDA decision documents: 510(k) Premarket Notification - FDA

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
K261338
Regulatory pathway
510(k) premarket notification
Product code
OMP
Decision code
SESE
Decision date
Sep 11, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Negative Pressure Wound Therapy Powered Suction Pump.

Product code
OMP
FDA device class
2

FDA decision timeline

  1. K261338 received

    Application receipt date recorded by FDA.

  2. K261338 · FDA decision

    SESE

Related devices and submissions

Explore the linked device profile

Other records with product code OMP

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Smith & Nephew Medical, Ltd.

Headquarters
Not reported
Brand website
smith-nephew.com
FDA applicant address
Hull

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records